Biomedical subjects
Tomas A Salerno
Publications and source records attributed to Tomas A Salerno.
Initial experience with sutureless proximal anastomoses performed with a mechanical connector leading to clampless off-pump coronary artery bypass surgery.
BACKGROUND: We report our early experience with the Symmetry Aortic Connector (St. Jude Medical, St. Paul, MN) used for sutureless proximal aortosaphenous vein graft anastomoses without any cross clamp during coronary bypass procedures. METHODS: Between November 2001 and August 2002, 206 saphenous vein to aorta proximal anastomoses were created in 132 patients using the Symmetry device. All procedures were performed as part of off-pump coronary artery bypass surgery without any aortic clamping. Intraoperative variables and postoperative data were collected and analyzed retrospectively. RESULTS: All 206 anastomoses (100%) were successfully completed with the connector. Severe atherosclerotic disease of the aorta was documented in 16 patients (12%). Four anastomoses (2%) required additional suture placement. Predeployment problems occurred with 3 grafts (2.5%) during loading of the connector. Average number of distal bypasses was 3.2 per patient. One patient (0.7%) required reoperation for bleeding from a proximal anastomosis. Six patients (4.5%) had perioperative myocardial infarction documented by electrocardiographic changes. Thirty-day operative mortality was 3% (4 patients). Intraoperative transit time flow measurement was performed in all cases (100%). Postoperative angiography in 43 patients at a median 3 months postoperatively revealed occlusion of 9 of the 81 saphenous vein grafts (11%). CONCLUSIONS: The initial experience with a proximal saphenous vein graft to aorta anastomosis using the Symmetry connector demonstrates safety and ease of use. There is however some concern with early graft closure. A prospective randomized study is needed to clarify these concerns.
Beating-heart valve surgery in patients with renal failure requiring hemodialysis.
BACKGROUND AND AIM OF THE STUDY: The safety and efficacy of beating-heart valve surgery as a myocardial protection strategy was evaluated in patients with renal failure requiring hemodialysis. METHODS: This was a retrospective review of nine patients (four males, five females; mean age 46.7 years; mean duration of hemodialysis 47 +/- 49 months) who underwent beating-heart valve surgery at the present authors' institution between April 2000 and September 2002. RESULTS: The mean cardiopulmonary bypass time was 77.2 +/- 8 min. Perioperatively, two patients died (one from sepsis; one from complication of anticoagulation). There were no deaths in the follow up since discharge, with average follow up 18.3 months (range: 9-27 months). Other complications included reintubation for <24 h (one case), AV graft thrombosis (one patient) and stroke (one patient, as mentioned above). There were no new cardiac (including arrhythmia and low cardiac output syndrome) or metabolic complications (including hyperkalemia and fluid overload). CONCLUSION: This is the first report of beating-heart valve surgery using simultaneous antegrade and retrograde perfusion with normothermic blood. Despite being small in size, the study demonstrated the safety of this approach in a high-risk population with renal failure requiring hemodialysis. The results suggested a low incidence of complications, and short ICU and hospital stays.
Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center.
BACKGROUND: The long-term benefits of angioplasty are limited by the occurrence of restenosis. Drug-eluting stents with a projected restenosis rate of close to 0% are soon to become available. The short- and long-term consequences of this advance to the cardiac surgical volume remain unclear. METHODS: A total of 196 consecutive coronary angiograms and medical records of patients referred for coronary bypass surgery were reviewed. Considering the hypothetical premise of having drug-eluting stents with a near zero restenosis rate, we reviewed each case to determine if surgical revascularization was still the preferred option for revascularization. RESULTS: The mean age was 60 (+/-10.6) years. Seventy-two percent of patients were male. Considering the availability of drug-eluting stents 154 (79%) would still have been sent to surgery, representing a 21% decrease in the number of surgical revascularizations. Angiographic characteristics predicting coronary bypass revascularization were the presence of chronic total occlusion (odds ratio [OR]: 9.1; confidence interval [CI]: 2.1 to 39), left main coronary artery stenosis (OR: 9.6; CI: 1.27 to 73), and need for valvular surgery (OR: 7.38; CI: 1.3 to 157). The most common predictors of a change in clinical management from surgical to percutaneous revascularization if drug-eluting stents were available were diffuse coronary narrowing (OR: 15.78), restenotic lesions (OR: 27.86), and small coronary arteries (OR: 26). CONCLUSIONS: Drug-eluting stents may have a significant impact on cardiac surgery volume (approximately a 21% decrease in our center). It may also direct patients with small vessels, diffuse narrowing, or restenotic lesions and diabetic patients to percutaneous therapy.
Beating heart valvular surgery.
Explore the source record for details and available documents.
Thoracic epidural anesthesia for cardiac surgery via left anterior thoracotomy in the conscious patient.
BACKGROUND: Cardiac surgery is perceived to be maximally invasive and fraught with complications. In response to this perception, cardiothoracic surgeons have been refining traditional techniques to minimize their invasive nature. Epidural anesthesia has been used safely and effectively for numerous surgical procedures to reduce morbidity associated with general anesthesia. In hopes of achieving a similar result, we set out to determine the feasibility of using thoracic epidural anesthesia for limited cardiac surgery through a left anterior thoracotomy for patients who were awake and spontaneously breathing. METHODS: A high thoracic epidural technique was used in all cases. In each instance, the chest was entered through a small left anterior thoracotomy. The procedures included minimally invasive direct coronary artery bypass (MIDCAB) and transmyocardial revascularization (TMR). These procedures were performed in routine fashion using standard techniques. Pulmonary function tests were performed preoperatively, and the adequacy of respiratory function was serially monitored throughout each operation. The epidural catheters were left in place for 24 hours after operation for pain control. RESULTS: A total of 10 operations were performed. These included 7 MIDCAB, 2 TMR and 1 MIDCAB/TMR hybrid. The mean preoperative forced expiratory volume for one second (FEV1) was 1.9 liters. Significant intra-operative hypoxia or hypercarbia was not seen. One patient required intubation during the procedure for restlessness not associated with hypoxia. Two others required brief periods of assisted ventilation. All procedures were completed without incident. The mean operating time and length of stay were 70 minutes and 4.7 days. Postoperative pain control and patient satisfaction were excellent. CONCLUSIONS: Thoracic epidural anesthesia for limited cardiac surgical procedures by means of a left anterior thoracotomy is feasible, even in patients with diminished pulmonary function. Furthermore, this method offered no significant technical hurdles. Nevertheless, the applicability of this technique to other procedures remains unclear. We believe that these results warrant controlled comparison of regional versus general anesthesia for limited cardiac surgery.
How to start a beating heart coronary artery surgery program.
An important issue that is not addressed in the recent literature on beating heart coronary artery bypass surgery is the question of how to initiate a program in OPCAB in a center where conventional coronary artery surgery has been the routine. It is the aim of this article to describe what we consider to be safe steps for a conventional cardiac surgeon to take to ensure a successful initiation of OPCAB surgery in his or her institution. While modern OPCAB surgery has experienced major technical advances that have made the procedure more predictably successful than in previous years, these advances require the use of an array of new technology and skills. This article discusses some of the skills and devices, such as modern stabilizers, shunts, and blowers, that the beginning OPCAB surgery team will need to acquire and master when embarking on an OPCAB program. Initiation of an OPCAB program also requires that the entire surgery team believe in the efficacy of the procedure and approach it with enthusiasm. A team visit to a center that already performs OPCAB is an important element in initiating the new program. It is no longer necessary to learn the procedures by trial and error. Because it will occasionally be necessary to convert from OPCAB to conventional surgery, the team must be thoroughly familiar with both methods and should not be reluctant to rely on the heart-lung machine when the patient's safety requires it.
The history and development of direct coronary surgery without cardiopulmonary bypass.
The history of direct myocardial revascularization without cardiopulmonary bypass dates to 1961 in the dawn of coronary artery surgery. With the introduction and development of techniques of extracorporeal circulation around the same time, beating heart surgery was largely abandoned. Over the subsequent decades, cardiopulmonary bypass and electromechanical cardioplegic arrest became popular as means of revascularization in a bloodless and motionless field. While coronary artery surgery on the arrested heart remained undisputed for decades, myocardial revascularization on the beating heart was pursued by a few pioneering surgeons around the world, based on the belief that coronary revascularization could be performed equally well without the detrimental effects of cardiopulmonary bypass and electromechanical arrest. Various concepts and techniques developed during the 1980s by these pioneers enabled minimally invasive coronary surgery to be performed in the early 1990s. This break from the mainstream allowed selective myocardial revascularization using a minimal incision and no cardiopulmonary bypass to develop and constructed a base for future extensive revascularizations off-pump. With the subsequent explosion of new techniques for coronary exposure and myocardial stabilization, complete revascularization without cardiopulmonary bypass became possible with consistent results. Emerging from the preview of only a few surgeons just a decade ago, off-pump surgery is currently one of the accepted modalities for complete myocardial revascularization worldwide. This paradigm shift in the approach to myocardial revascularization has led to exiting new future possibilities, such as beating heart totally endoscopic coronary artery surgery.
Beating-heart valvular surgery: a possible alternative for patients with severely compromised ventricular function.
Cardioplegic arrest of the severely compromised ventricle may make weaning from cardiopulmonary bypass problematic. We report a novel approach to myocardial protection in a patient requiring multi-valve surgery who had an ejection fraction of 15%. Warm oxygenated blood was infused continuously both antegrade and retrograde during aortic valve replacement and mitral and tricuspid valve repair. Adequacy of perfusion was confirmed by the absence of electrocardiographic changes. Clinical improvement suggests that this strategy of myocardial protection warrants further investigation.
Simultaneous antegrade/retrograde normothermic perfusion with blood (beating heart) for aortic root replacement in acute type-a dissection of the aorta.
A new technique of myocardial protection was utilized in performing surgery for acute type-A dissection involving the aortic valve, requiring replacement of the root. Simultaneous antegrade and retrograde perfusion of the heart with normothermic blood at high flows allows for safe and precise surgery, without concerns for the period of aortic clamping, since ischemia is eliminated altogether.
Modified sternotomy to minimize infection risk in patients with prior laryngectomy and permanent tracheostomy.
Explore the source record for details and available documents.